日本語English简体中文 繁體中文

4978 ReproCELL IncorporatedリプロセルTSE Growth / Chemicals

0 posts

ReproCELL Incorporated (4978) at a glance

Code
4978
Company
ReproCELL Incorporated
Local name
リプロセル
Market
TSE Growth
Sector
Chemicals
Share price
¥105 -5.0 (-4.55%) Nov 20 close

Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.

ReproCELL Incorporated (4978) Stock Price HistoryNear an all-time low

ReproCELL Incorporated closed at ¥105 on Nov 20, 2026, −12.5% over 1 month, −34.4% over 1 year.

2026-10-20 株式及び新株予約権発行プログラム設定契約に基づく第4回第三者割当による新株式及…2026-11-12 2027年3月期 第2四半期(中間期)決算短信〔日本基準〕(連結)¥126¥105Oct 20Nov 20
Price5-day MA25-day MANikkei 225Disclosures
1-Month High¥126Oct 28
1-Month Low¥105Nov 18
1-Week Change−3.7%vs Nov 13
1-Month Change−12.5%vs Oct 20

If you had invested ¥100,000 1 month ago, it would be worth ¥87,500 today (−12.5%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −11.9%, while this stock moved −12.5%.

Last 10 Trading Days

DateCloseChange% Change
Nov 20 (Fri)¥105−5−4.55%
Nov 19 (Thu)¥110+5+4.76%
Nov 18 (Wed)¥105−2−1.87%
Nov 16 (Mon)¥107−2−1.83%
Nov 13 (Fri)¥109+0+0.00%
Nov 12 (Thu)¥109−6−5.22%
Nov 11 (Wed)¥115+3+2.68%
Nov 10 (Tue)¥112+4+3.70%
Nov 9 (Mon)¥108+2+1.89%
Nov 6 (Fri)¥106−7−6.19%
2026-09-03 株式及び新株予約権発行プログラム設定契約に基づく第3回第三者割当による新株式及…2026-10-05 株式及び新株予約権発行プログラム設定契約に基づく第4回第三者割当による新株式及…2026-10-20 株式及び新株予約権発行プログラム設定契約に基づく第4回第三者割当による新株式及…2026-11-12 2027年3月期 第2四半期(中間期)決算短信〔日本基準〕(連結)¥154¥105Aug 20Nov 20
Price5-day MA25-day MANikkei 225Disclosures
3-Month High¥154Aug 20
3-Month Low¥105Nov 18
1-Month Change−12.5%vs Oct 20
3-Month Change−31.8%vs Aug 20

If you had invested ¥100,000 3 months ago, it would be worth ¥68,182 today (−31.8%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −14.8%, while this stock moved −31.8%.

Last 10 Trading Days

DateCloseChange% Change
Nov 20 (Fri)¥105−5−4.55%
Nov 19 (Thu)¥110+5+4.76%
Nov 18 (Wed)¥105−2−1.87%
Nov 16 (Mon)¥107−2−1.83%
Nov 13 (Fri)¥109+0+0.00%
Nov 12 (Thu)¥109−6−5.22%
Nov 11 (Wed)¥115+3+2.68%
Nov 10 (Tue)¥112+4+3.70%
Nov 9 (Mon)¥108+2+1.89%
Nov 6 (Fri)¥106−7−6.19%
2026-09-03 株式及び新株予約権発行プログラム設定契約に基づく第3回第三者割当による新株式及…2026-10-05 株式及び新株予約権発行プログラム設定契約に基づく第4回第三者割当による新株式及…2026-10-20 株式及び新株予約権発行プログラム設定契約に基づく第4回第三者割当による新株式及…2026-11-12 2027年3月期 第2四半期(中間期)決算短信〔日本基準〕(連結)¥155¥105May 20Nov 20
Price25-day MA75-day MANikkei 225Disclosures
6-Month High¥155Aug 18
6-Month Low¥105Nov 18
3-Month Change−31.8%vs Aug 20
6-Month Change−23.4%vs May 20

If you had invested ¥100,000 6 months ago, it would be worth ¥76,642 today (−23.4%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −5.6%, while this stock moved −23.4%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026¥105−13.9%
Oct 2026¥122−14.1%
Sep 2026¥142−6.0%
Aug 2026¥151+18.9%
Jul 2026¥127+2.4%
Jun 2026¥124−3.9%
May 2026¥129−25.0%
2026-09-03 株式及び新株予約権発行プログラム設定契約に基づく第3回第三者割当による新株式及…2026-10-05 株式及び新株予約権発行プログラム設定契約に基づく第4回第三者割当による新株式及…2026-10-20 株式及び新株予約権発行プログラム設定契約に基づく第4回第三者割当による新株式及…2026-11-12 2027年3月期 第2四半期(中間期)決算短信〔日本基準〕(連結)¥192¥105Nov 20Nov 20
Price25-day MA75-day MANikkei 225Disclosures
52-Week High¥192Mar 6
52-Week Low¥105Nov 18
Year to Date−25.0%vs Dec 30
From 52-Week High−45.3%Mar 6

If you had invested ¥100,000 1 year ago, it would be worth ¥65,625 today (−34.4%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +13.3%, while this stock moved −34.4%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026¥105−13.9%
Oct 2026¥122−14.1%
Sep 2026¥142−6.0%
Aug 2026¥151+18.9%
Jul 2026¥127+2.4%
Jun 2026¥124−3.9%
May 2026¥129−25.0%
Apr 2026¥172−2.3%
Mar 2026¥176−6.4%
Feb 2026¥188+18.2%
Jan 2026¥159+13.6%
Dec 2025¥140−13.6%
Nov 2025¥162―
¥226¥100Nov 20, 2023Nov 20, 2026
Price13-week MA26-week MANikkei 225
3-Year High¥226Jul 7, 2025
3-Year Low¥100Dec 16, 2024
Annualized Return−21.5%
Max Drawdown−53.9%

If you had invested ¥100,000 3 years ago, it would be worth ¥48,387 today (−51.6%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +67.8%, while this stock moved −51.6%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥105−25.0%
2025¥140―
¥337¥100Nov 22, 2021Nov 20, 2026
Price13-week MA26-week MANikkei 225
5-Year High¥337Dec 12, 2022
5-Year Low¥100Dec 16, 2024
Annualized Return−14.1%
Max Drawdown−70.3%

If you had invested ¥100,000 5 years ago, it would be worth ¥46,875 today (−53.1%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +96.3%, while this stock moved −53.1%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥105−25.0%
2025¥140―
¥2,161¥104Jul 1, 2013Nov 20, 2026
Price1-year MA2-year MANikkei 225
All-Time High¥2,161Sep 2013
All-Time Low¥104Dec 2024
Total Change−94.8%vs Jul 2013
Annualized Return−19.8%

If you had invested ¥100,000 in Jul 2013, it would be worth ¥5,234 today (−94.8%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +290.4%, while this stock moved −94.8%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥105−25.0%
2025¥140+34.6%
2024¥104−40.6%
2023¥175−42.2%
2022¥303+28.4%
2021¥236−42.6%
2020¥411+94.8%
2019¥211+10.5%
2018¥191−39.9%
2017¥318−26.0%
2016¥430+17.5%
2015¥366−52.7%
2014¥773−55.2%
2013¥1,725―

Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Jul 2013). Please check the latest prices before trading.

ReproCELL Incorporated (4978) financial indicators

PBR
1.06
ROE
-4.52%
Dividend yield
0.00%

See all financial indicators for ReproCELL Incorporated (market cap, DOE, equity ratio, EV, EBITDA, ROIC and more)

PER, ROE and dividend yield are based on company forecasts, calculated from earnings reports and the closing price after each trading day.

Key features of ReproCELL Incorporated (4978)

Business overview

Built around iPS cell technology, the company runs two businesses: research support and medical. The research support business serves universities, public research institutes and drug makers, making and selling research products for iPS cell research such as culture media, antibodies and reprogramming reagents, providing contract research services, and selling cell measurement instruments; it serves as the short- to medium-term revenue base. The medical business researches and develops regenerative medicine products centered on four products (Stemchymal, iPS neural glial cell products, TIL therapy and GPC-1 CAR-T therapy), provides contract manufacturing of such products, and offers clinical testing services; it is positioned as the pillar of medium- to long-term growth. It has subsidiaries in the US, the UK and India.

Summarized from the annual securities report (fiscal year ended March 2026) filed on EDINET.

Position within Chemicals (202 companies)

PBR1.06xAbove the sector median of 0.85x (No. 132 from the lowest)
ROE-4.52%No. 187 in the sector (highest first); median 7.83%
Market cap¥10.9 bnNo. 145 in the sector (largest first)

Ranks among stocks in the same Tokyo Stock Exchange sector (33 sectors). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest.

Price milestones

52-week high¥1923/6
52-week low¥10511/20
Current position0.0%Where the low is 0% and the high is 100% (close on 11/20: ¥105)
Year to date-25.0%No. 187 of 200 in the sector (best first)
1 year-34.4%

Based on closing prices (adjusted for stock splits, excluding dividends).

Kabutaro's ranking history

Top 50 losers2 timesLatest: 10/8 (No. 21)

Gainers and losers have been recorded since 9/2026.

Calculated as of 2026/11/20 17:30 JST. Updated every business day in the evening.

Recent disclosures (TDnet, in Japanese)

Filings from the past 12 months (5).

Posts

This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.

No posts yet. Be the first to write something.

Write on the ReproCELL Incorporated board

You will need this to delete your post. Please keep it safe.
By posting you agree to the board rules (Japanese). You are responsible for what you write.

More Japanese stocks in English

Japanese Stock Message Board: stocks available in English

Other boards in English